Probiotics for women’s health: new evidence in post-menopausal women

Harnessing the benefits of L. plantarum PBS067, L. rhamnosus LRH020, and B. lactis BL050 for post-menopausal symptom relief.

Immune signaling can influence tumors growth through microbial regulation

The findings of a recent study suggest that the crosstalk between gut microbes and the host’s immune system can influence the body’s defenses during cancer therapy.

Gut microbe eases social difficulties associated with autism, small clinical trial shows

The findings of a recent study suggest that L. reuteri eases social difficulties in autistic children.

Freya Biosciences: pioneering the development of microbial immunotherapies for women’s health

Johan van Hylckama Vlieg, CSO and Co-founder of Freya Biosciences, discusses the latest advancements in microbial immunotherapies for women's health.

The PICASSO trial: painting a new future for melanoma patients

MaaT Pharma indicates completion of patient recruitment for the Phase 2a RCT Evaluating MaaT013 in combination with immune checkpoint inhibitors in metastatic melanoma.

Gut microbes may promote the recovery of liver function in cancer patients

The findings of a recent study suggest that modulating the gut microbiota in people with liver cancer can improve their health outcomes after surgery.

How vaginal microbes are linked to pregnancy complications

The findings of a recent study suggest that in bacterial vaginosis, certain vaginal microbes disrupt the protective glycans on vaginal epithelial cells, altering processes that mediate cell turnover, death and…

Clinical Microbiomics acquires DNASense to expand frontier technologies

This strategic acquisition is set to reshape the landscape of microbiome research, extending its applications far beyond human health.

Innovative Frontiers: AI-Driven Approaches to Microbiological Analysis

An open discussion about the future of microbiological analysis through AI integration with Franco Pirovano (Micro srl) and Federico Pirovano (Dynius).

Engineering Live biotherapeutics to treat complex respiratory diseases

Maria Lluch Senar, Founder and Chief Scientific Officer at Pulmobiotics SL, discusses the research on engineering Live Biotherapeutics in order to expose antigens or deliver therapeutic agents to treat complex…

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top